Premium
Commentary: tenofovir is superior to entecavir in HBeAg‐positive chronic hepatitis B patients – authors' reply
Author(s) -
Gao L.,
Trinh H. N.,
Li J.,
Nguyen M. H.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12708
Subject(s) - entecavir , tenofovir , medicine , chronic hepatitis , hbeag , gastroenterology , virology , hepatitis b , population , prospective cohort study , hepatitis b virus , virus , lamivudine , hbsag , environmental health , human immunodeficiency virus (hiv)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom